OIS
ABBV icon

OneAscent Investment Solutions’s AbbVie ABBV Stock Holding History

OneAscent Investment Solutions’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$320K Sell
1,271
-297
-19% -$63.9K 0.3% 82
2026
Q1 		$341K Buy
1,568
+5
+0.3% +$1.11K 0.34% 80
2025
Q4 		$357K Buy
1,563
+141
+10% +$32.1K 0.38% 75
2025
Q3 		$329K Buy
1,422
+212
+18% +$43.2K 0.35% 83
2025
Q2 		$225K Sell
1,210
-365
-23% -$67.8K 0.24% 123
2025
Q1 		$330K Buy
+1,575
New +$306K 0.39% 80

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

OneAscent Investment Solutions's ABBV Position: Q2 2026 in Review

OneAscent Investment Solutions reduced its AbbVie (ABBV) stake by 19% in Q2 2026, selling an estimated $63.9K and leaving 1,271 shares worth $320K. The position accounts for 0.3% of the portfolio, ranked #82.

OneAscent Investment Solutions first reported a position in ABBV in Q1 2025 and has held it in 6 quarters since. The position peaked at $357K in Q4 2025. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • OneAscent Investment Solutions held 1,271 shares of AbbVie worth $320K as of Q2 2026.
  • OneAscent Investment Solutions sold 297 AbbVie shares in Q2 2026, an estimated $63.9K.
  • AbbVie made up 0.3% of OneAscent Investment Solutions's portfolio in Q2 2026, its #82 holding.
  • OneAscent Investment Solutions first reported a position in AbbVie in Q1 2025 and has held it in 6 quarters since.
  • OneAscent Investment Solutions's AbbVie position peaked at $357K in Q4 2025.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on OneAscent Investment Solutions's 13F filing for Q2 2026, filed 11 Aug 2026.